NOVN.VX : Summary for NOVARTIS N - Yahoo Finance

U.S. Markets closed


Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
68.50-0.25 (-0.36%)
At close: 11:30 AM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close68.75
Bid0.00 x 373700
Ask0.00 x 1281100
Day's Range67.85 - 68.75
52 Week Range67.40 - 79.80
Avg. Volume5,808,735
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Financial Times10 days ago

    [$$] Big Pharma healthcare R&D steps out into the open

    On Chicago's outskirts sits a sprawling corporate campus set on more than 450 acres. It is home to Abbott Laboratories, the healthcare group, and AbbVie, the drugmaker it spun out in 2013. A grid of roads ...

  • Financial Times13 days ago

    [$$] J&J confirms talks with Actelion over pharma deal

    Johnson & Johnson, the world's largest healthcare group, confirmed on Friday that it is in preliminary discussions with Actelion, Europe's largest biotechnology company, over a potential deal. Its statement ...

  • MarketWatch18 days ago

    Novartis buys U.S.-based sickle cell drugmaker Selexys

    Novartis AG has acquired U.S.-based Selexys Pharmaceuticals Corp., a developer of therapeutics for blood and inflammatory disorders, the Swiss drug maker said in a statement Monday. The terms of the deal ...